Cargando…

Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells

Retigeric acid B (RAB), a natural compound isolated from lichen, has been demonstrated to inhibit cell growth and promote apoptosis in prostate cancer (PCa) cells. The present study evaluated the function of RAB combined with clinical chemotherapeutic drugs in PCa cell lines by MTT assay, reverse tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yongqing, Yue, Chunwen, Li, Juan, Wu, Jing, Wang, Shikang, Sun, Deqing, Guo, Yanxia, Lin, Zhaomin, Zhang, Denglu, Wang, Rongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778852/ https://www.ncbi.nlm.nih.gov/pubmed/29435013 http://dx.doi.org/10.3892/ol.2017.7664

Ejemplares similares

Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-κB Signaling in Prostate Cancer Cells in Vitro and in Vivo
por: Liu, Yong-Qing, et al.
Publicado: (2012)

Retigeric Acid B Attenuates the Virulence of Candida albicans via Inhibiting Adenylyl Cyclase Activity Targeted by Enhanced Farnesol Production
por: Chang, Wenqiang, et al.
Publicado: (2012)

Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity
por: Kothandapani, Anbarasi, et al.
Publicado: (2013)

Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994)

Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL6 and P21 expression
por: Zhang, Denglu, et al.
Publicado: (2019)

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance
por: Li, Juan, et al.
Publicado: (2020)

Dr. D. Eugene Block
Publicado: (1917)

Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines
por: Abdullah, Nada, et al.
Publicado: (2021)

Regulation of Cisplatin Cytotoxicity by Cu Influx Transporters
por: Abada, Paolo, et al.
Publicado: (2010)

Ultrasound-targeted microbubble destruction-mediated miR-205 enhances cisplatin cytotoxicity in prostate cancer cells
por: Qin, Dingwen, et al.
Publicado: (2018)

Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis
por: Enoiu, Milica, et al.
Publicado: (2012)

Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae
por: Inapurapu, Santhi priya, et al.
Publicado: (2017)

MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability
por: Clodfelter, Jill E., et al.
Publicado: (2005)

Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest
por: Koprinarova, Miglena, et al.
Publicado: (2010)

Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
por: Khan, Muhammad Muzamil, et al.
Publicado: (2020)

Mitochondrial Involvement in Cisplatin Resistance
por: Cocetta, Veronica, et al.
Publicado: (2019)

Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment
por: Hasan, Aseel Ali, et al.
Publicado: (2023)

A Mechanism for the Temporal Potentiation of Genipin to the Cytotoxicity of Cisplatin in Colon Cancer Cells
por: Wang, Ruihua, et al.
Publicado: (2016)

Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells
por: Kumar, Sanjay, et al.
Publicado: (2015)

Nanostructures Control the Hepatocellular Responses to a Cytotoxic Agent “Cisplatin”
por: Abdellatef, Shimaa A., et al.
Publicado: (2015)

Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
por: Spreckelmeyer, Sarah, et al.
Publicado: (2014)

Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells
por: Hwang, Pai-An, et al.
Publicado: (2017)

The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells
por: Pereira, Luiz Miguel, et al.
Publicado: (2023)

Efficacy of surgical repair for the functional restoration of injured facial nerve
por: Li, Li, et al.
Publicado: (2021)

Role of Nucleotide Excision Repair in Cisplatin Resistance
por: Duan, Mingrui, et al.
Publicado: (2020)

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair
por: Zhou, Ting, et al.
Publicado: (2019)

Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma
por: Zhaomin, Song, et al.
Publicado: (2015)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells
por: Ho, Winson S., et al.
Publicado: (2016)

Metabolic interaction between amino acid deprivation and cisplatin synergistically reduces phosphoribosyl-pyrophosphate and augments cisplatin cytotoxicity
por: Wahwah, Nisreen, et al.
Publicado: (2020)

Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
por: Wang, Shikang, et al.
Publicado: (2019)

Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
por: VOON, YEE-LIN, et al.
Publicado: (2015)

Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells
por: Osman, Abdel-Moneim M., et al.
Publicado: (2015)

α-Diimine Cisplatin Derivatives: Synthesis, Structure, Cyclic Voltammetry and Cytotoxicity
por: Yambulatov, Dmitriy S., et al.
Publicado: (2022)

Graphene Oxide Enhanced Cisplatin Cytotoxic Effect in Glioblastoma and Cervical Cancer
por: Kregielewski, Kacper, et al.
Publicado: (2023)

Overexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediated apoptosis
por: Liu, Jieying, et al.
Publicado: (2018)

Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
por: Minagawa, Yukihisa, et al.
Publicado: (1994)

The ferroptosis inducer erastin irreversibly inhibits system x(c)− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
por: Sato, Mami, et al.
Publicado: (2018)

α-Mangostin Enhances Betulinic Acid Cytotoxicity and Inhibits Cisplatin Cytotoxicity on HCT 116 Colorectal Carcinoma Cells
por: Aisha, Abdalrahim F. A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_glkn7o6glbu9563j2njlog1n5v